Interleukin-1 (IL-1) receptor type I mediates anorexia but not adipsia induced by centrally administered IL-1

Physiology and Behavior

Volumn 62, Issue 5, 1997, Pages 1179-1183

  Sonti, Gayatri ^a   Flynn, Mark C ^a   Plata Salamán, Carlos R ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Antisense; Beha vior; Central nervous system; Cerebrospinal fluid; Cytokine; Drinking; Feeding; Food intake; Growth factor; Intracerebroventricular administration; Nervous system; Neuroimmunology; Oligonucleotide; Rat; Water intake

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA;

ADIPSIA; ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEEDING BEHAVIOR; FLUID INTAKE; FOOD INTAKE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0030771444     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)80019-4     Document Type: Article

References (24)

1. Arend, W. P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest. 88:1445-1451; 1991.
2. Burch, R. M.; Mahan, L. C. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice. J. Clin. Invest. 88:1190-1196; 1991.
3. Hart, R. P.; Liu, C.; Shadiack, A. M.; McCormack, R. J.; Miller Jonakait, G. An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia. J. Neuroimmunol. 44: 49-56; 1993.
4. López-Cortés, L. F.; Cruz-Ruiz, M.; Gómez-Mateos, J.; Jiménez-Hernández, D.; Palomino, J.; Jiménez, E. Measurement of levels of tumor necrosis factor-α and interleukin-1β in the CSF of patients with meningitis of different etiologies: Utility in the differential diagnosis. Clin. Infect. Dis. 16:534-539; 1993.
5. Malinowsky, D.; Chai, Z.; Bristulf, J.; Simoncsits, A.; Bartfai, T. The type I interleukin-1 receptor mediates fever in the rat as shown by interleukin-1 receptor subtype selective ligands. Neurosci. Lett. 201: 33-36; 1995.
6. 2 release from rat hypothalamus is mediated by type I and type II interleukin-1 receptors. J. Neuroimmunol. 61:171-177; 1995.
7. Mugridge, K. G.; Perretti, M.; Ghiara, P.; Galeotti, C. L.; Melli, M.; Parente, L. Gastric antisecretory and anti-ulcer actions of IL-1 in rat involve different IL-1 receptor types. Am. J. Physiol. 269:G763-G769; 1995.
8. Ogawa, S.; Brown, H. E.; Okano, H. J.; Pfaff, D. W. Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain. Regul. Peptides 59:143-149; 1995.
9. Oldenburg, H. S. A.; Pruitt, J. H.; Lazarus, D. D.; Rogy, M. A.; Chizzonite, R.; Lowry, S. F.; Moldawer, L. L. Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response. Cytokine 7:510-516; 1995.
10. Plata-Salamán, C. R. Immunoregulators in the nervous system. Neurosci. Biobehav. Rev. 15:185-215; 1991.
11. Plata-Salamán, C. R. Interferons and central regulation of feeding. Am. J. Physiol. 263:R1222-R1227; 1992.
12. Plata-Salamán, C. R. Meal patterns in response to the intracerebroventricular administration of interleukin-1β in rats. Physiol. Behav. 55: 727-733; 1994.
13. Plata-Salamán, C. R. Cytokine action in the nervous system at pathophysiological versus pharmacological concentrations. In: Friedman, H.; Eisenstein, T. K.; Madden, J.; Sharp, B. M., eds. AIDS, Drugs of Abuse and the Neuroimmune Axis. New York: Plenum Press; 1996: 191-197.
14. Plata-Salamán, C. R.; ffrench-Mullen, J. M. H. Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1β. Physiol. Behav. 51:1277-1279; 1992.
15. 1 neurons through protein kinase. C. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 266:1-10; 1994.
16. 2-microglobulin, a marker of immune activation. Am. J. Physiol. 268:R1513-R1519; 1995.
17. αOA subunit. Mol. Brain Res. 33:72-78; 1995.
18. Sims, J. E.; Gayle, M. A.; Slack, J. L.; Alderson, M. R.; Bird, T. A.; Giri, J. G.; Colotta, F.; Re, F.; Mantovani, A.; Shanebeck, K.; Grabstein, K. H.; Dower, S. D. Interleukin-1 signalling occurs exclusively via the type 1 receptor. Proc. Natl. Acad. Sci. USA 90:6155-6159; 1993.
19. Sonti, G.; Ilyin, S. E.; Plata-Salamán, C. R. Anorexia induced by cytokine interactions at pathophysiological concentrations. Am. J. Physiol. 270:R1394-R1402; 1996.
20. Szklarczyk, A.; Kaczmarek, L. Antisense oligodeoxynucleotides: stability and distribution after intracerebral injection into rat brain. J. Neurosci. Meth. 60:181-187; 1995.
21. Vogels, M. T. E.; Eling, W. M. C.; Otten, A.; Van der Meer, J. W. M. Interleukin-1 (IL-1)-induced resistance to bacterial infection: Role of the type I IL-1 receptor. Antimicrob. Agents Chemother. 39:1744-1747; 1995.
22. Wahlestedt, C. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15:42-46; 1994.
23. Whitesell, L.; Geselowitz, D.; Chavany, C.; Fahmy, B.; Walbridge, S.; Alger, J. R.; Neckers, L. M. Stability, clearance, and disposition of intraventricularly administered oligonucleotides. Implications for therapeutic application within the central nervous system. Proc. Natl. Acad. Sci. USA 90:4665-4669; 1993.
24. Yaida, Y.; Nowak Jr, T. S. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization. Regul. Peptides 59:193-199; 1995.